Clinical features of 28 cases of anti-leucine-rich glioma-inactivated protein 1 encephalitis and anti-contactin-associated protein-like 2 encephalitis.
Feng J, Li J, Xie Y, Lü Y, Bi F, Zhou J.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Mar 28;48(3):386-396. doi: 10.11817/j.issn.1672-7347.2023.220548.
PMID:37164922
Inhibitory axons are targeted in hippocampal cell culture by anti-Caspr2 autoantibodies associated with limbic encephalitis.
Pinatel D, Hivert B, Boucraut J, Saint-Martin M, Rogemond V, Zoupi L, Karagogeos D, Honnorat J, Faivre-Sarrailh C.
Front Cell Neurosci. 2015 Jul 9;9:265. doi: 10.3389/fncel.2015.00265. eCollection 2015.
PMID:26217189
Cytokine changes during treatment of anti-Caspr2 encephalitis: a case report.
Wei YC, Wu CL, Weng WC.
BMC Neurol. 2020 Aug 13;20(1):299. doi: 10.1186/s12883-020-01879-x.
PMID:32791989
Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.
Grativvol RS, Cavalcante WCP, Castro LHM, Nitrini R, Simabukuro MM.
Curr Oncol Rep. 2018 Nov 10;20(11):92. doi: 10.1007/s11912-018-0721-y.
PMID:30415318
Antibody-positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series.